CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Botulinum Toxin Type A - OnabotulinumtoxinA +1 moredrug
Likely dose
Botulinum Toxin Type A - OnabotulinumtoxinA 200 unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00661089
NCT00661089N/ACompleted

"A Randomized Double-Blind Placebo-Controlled Trial of Botulinum Toxin Type A (BOTOX ) in the Treatment of Hemiplegic Shoulder Pain and Spasticity"

Shirley Ryan AbilityLab·interventional·Posted Apr 18, 2008·Updated Nov 13, 2020

In Brief

A clinical study evaluating Botulinum Toxin Type A - OnabotulinumtoxinA and Placebo (Saline) for Post-stroke Shoulder Pain and Spasticity. Completed, enrolled 21 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate whether botulinum toxin type A injected into muscles around the shoulder is effective in treating shoulder pain and improving function in patients with shoulder pain and involuntary muscle tightness after a stroke.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsAllergan

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 18, 2008
Enrollment StartSep 1, 2003
Primary CompletionMar 1, 2009
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 18.2 years ago

Interventions

Botulinum Toxin Type A - OnabotulinumtoxinAdrug

100-200 units injected into the pectoralis major. The teres major may also be injected if tone is noted in shoulder extensors.

Placebo (Saline)drug

Equivalent volume of saline without study drug injected into the pectoralis major. Teres major was also injected if tone noted in the shoulder extensors.